Conversely, Cat K could inactivate TGF-β1 and restrict excessive ECM deposition to control lung fibrosis [35], and Cat S may proteolytically inactivate Cat K and thus would control its collagenolytic or elastinolytic activity [36]. Here, CAT is linked to pulmonary fibrosis.